Le Lézard
Classified in: Health
Subjects: CCA, FVT

Hologic to Announce Financial Results for the First Quarter of Fiscal 2018 on Thursday, February 8, 2018


MARLBOROUGH, Mass., Jan. 8, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2018 on Thursday, February 8, 2018, after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.

Interested participants may listen to the call by dialing 800-281-7973 (in the United States) or +1 323-794-2093 (for international callers) and referencing access code 4501215.  Participants should dial in 5-10 minutes before the call begins.  A replay will be available approximately two hours after the call ends through Friday, March 2, 2018.  The replay numbers are 888-203-1112 (U.S.) or +1 719-457-0820 (international), access code 4501215, Pin 2953.

Hologic will provide a live webcast of the call on the Company's website at www.investors.hologic.com. The call will be archived there for 30 days. 

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

Contact

Paula Izidoro
Senior Investor Relations Specialist
(858) 410-8904
[email protected]

 

SOURCE Hologic, Inc.


These press releases may also interest you

at 23:00
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....



News published on and distributed by: